Delivery Order SPE2DB22D6029-SPE2DB25FLTUY

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of the pharmaceutical product NEXTERONE 150 MG/100 ML BAG 100ML, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $1,332.91 firm fixed-price delivery order has an ultimate completion date of October 21, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $1,021.58 for the supply of NEXTERONE 150 MG/100 ML BAG 100ML, a pharmaceutical product. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on February 22, 2023, with a completion date of February 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,319.70 firm fixed-price delivery order is for NEXTERONE 360 MG/200 ML BAG 200ML, a critical medical product. The award has an ultimate completion date of January 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,710.10 Firm Fixed Price Delivery Order is for NEXTERONE 360 MG/200 ML BAG 200ML, a pharmaceutical product. The award has an ultimate completion date of November 14, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FM3X7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has no set-aside designation, is a Firm Fixed Price Delivery Order valued at $2,287.98 for the supply of NEXTERONE 360 MG/200 ML BAG 200ML, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of NEXTERONE 150 MG/100 ML BAG 100ML, a pharmaceutical product. The contract has a ceiling value of $6,576.64 and a completion date of April 18, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies,...
This federal contract award, valued at $1,515.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
This federal contract award, valued at $1,018.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 29, 2025. This award is not associated with a set-aside program....
This federal contract award, valued at $14,093.59, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the purchase of NEXLIZET 180-10 MG TABLET in quantities of 30s. This award does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTUY
    Delivery Order

This federal contract award is for the pharmaceutical product NEXTERONE 360 MG/200 ML BAG 200ML, awarded by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract, valued at $2,431.10, is a delivery order with a firm fixed price. It has an ultimate completion date of January 27, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the military and veterans' healthcare systems. This contract award is associated with the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/25/25, 10:36 AM